Skip to main content

Table 3 Base line characteristics of participants enrolled in therapeutic efficacy study at 4 sentinel sites of Kisii County

From: Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment

Variables

Kenyenya

n (%) (n = 69)

Marani

n (%) (n = 69)

Bonchari

n (%) (n = 69)

Nyamache

n (%)(n = 68)

P value

Sub-Counties

Weight (kg), mean (SD)

44.8 ± 7.3

39.9 ± 15.5

36.4 ± 9.7

38.4 ± 8.5

0.15

Gender (male), n (%)

31 (44.9)

28 (40.5)

31 (44.9)

20 (28.9)

0.38

Gender (female), n (%)

38 (55.0)

41 (59.4)

38 (55.0)

48 (71.1)

0.51

Body temperature on day 0, °C, mean (SD)

37.6 °C ± 1.1

37.5 °C ± 1.1

37.8 °C ± 1.1

37.3 °C ± 1.1

0.002*

Asexual Parasites /µL on day 0* (95% CI)

11,4301 (7,256–12,785)

12,403 (8,242–13,565)

13,531 (9,242–15,603)

9,221 (7,308–11,252)

0.047*

Median age in years (males)

34.5

38.5

42.5

41.5

0.10

Age range in years (males)

(4–62)

(3–82)

(5–69)

(2–75)

0.172

Median age in years (females)

31.5

28.5

27.5

30.5

0.75

Age range in years (females)

(5–74)

(3–75)

(5–80)

(2–65)

0.125

  1. °C: degree Celsius; Temperature of ≥ 37.5 °C or history of fever during the previous 24 h. Parasitaemia*: geometric mean parasite density (asexual parasites/µL); n: number of patients; SD: standard deviation; 95% CI: 95% confidence interval; *p < 0.05, the mean was significantly different